Simon Englert
Chemiker
Hat mitgewirkt an:
-
Novel amino‐Li resin for water‐based solid‐phase peptide synthesis
-
Hybrid Multimeric Architectures for Enhanced Receptor Targeting and Intracellular Delivery of Bioactive Cargoes
-
Synthetic Integrin-Targeting Dextran-Fc Hybrids Efficiently Inhibit Tumor Proliferation In Vitro
-
Dextramabs: A Novel Format of Antibody‐Drug Conjugates Featuring a Multivalent Polysaccharide Scaffold